E71.529
X-linked adrenoleukodystrophy, unspecified type
Clinical Classification Guidelines
Medical Intelligence & Overview
X-linked adrenoleukodystrophy (ALD) is a genetic disorder that primarily affects the nervous system and adrenal glands. It is caused by a mutation in the ABCD1 gene, leading to the buildup of very long-chain fatty acids in the body. This accumulation damages the myelin, the protective covering of nerve fibers, and can cause dysfunction in various organs. The disorder is classified as X-linked, meaning it mainly affects males, although females can sometimes have mild symptoms. The unspecified type indicates that the specific subtype of ALD has not been detailed.
Causes & Symptoms
Clinical Causes: Genetic mutation in the ABCD1 gene on the X chromosome. Inheritance from a mother who carries the faulty gene. No environmental factors are known to cause this condition. The disorder is inherited in an X-linked pattern, affecting males more severely.
Key Symptoms: Progressive neurological issues such as difficulty walking, weakness, or paralysis. Problems with vision, hearing, or speech as the disease affects nerve pathways. Cognitive decline including memory loss and behavioral changes. Adrenal gland dysfunction leading to adrenal insufficiency symptoms like fatigue, weakness, and low blood pressure. Behavioral changes such as irritability, hyperactivity, or social withdrawal. Seizures in some cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of X-linked adrenoleukodystrophy involves a combination of clinical evaluation and laboratory testing. These may include:
Treatment Protocols: Currently, there is no cure for ALD. Treatment strategies focus on managing symptoms and slowing disease progression, including:
Clinical Advice & FAQs
Billing Guidance
Is E71.529 a billable ICD-10 code?
Yes, E71.529 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.529?
Clinical documentation must specify the nature of X-linked adrenoleukodystrophy, unspecified type and any associated comorbidities for accurate reporting.
Cite this Clinical Reference